Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis

被引：17
|
作者：
Asahina, Akihiko [1 ]
Ishii, Norihisa [3 ]
Tohma, Shigeto [2 ]
机构：
[1] Natl Hosp Org Sagamihara Natl Hosp, Dept Dermatol, Minami Ku, Sagamihara, Kanagawa 2520392, Japan
[2] Natl Hosp Org Sagamihara Natl Hosp, Dept Rheumatol, Sagamihara, Kanagawa 2520392, Japan
[3] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan
来源：
JOURNAL OF DERMATOLOGY | 2012年 / 39卷 / 02期
关键词：
THERAPY;
D O I：
10.1111/j.1346-8138.2011.01243.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：199 / 201
页数：3
相关论文
共 50 条
  • [41] Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-α treatment
    Bassetti, S
    Wasmer, S
    Hasler, P
    Vogt, T
    Nogarth, D
    Frei, R
    Widmer, AF
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2125 - 2129
  • [42] Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
    Yang, Nicole
    Huang, Jie
    Frits, Michelle
    Iannaccone, Christine
    Weinblatt, Michael E.
    Rifai, Nader
    Shadick, Nancy
    Bradwin, Gary
    Liao, Katherine P.
    [J]. PRACTICAL LABORATORY MEDICINE, 2019, 16
  • [43] TREATMENT DECISIONS FOLLOWING A DIAGNOSIS OF CANCER DURING TUMUOR NECROSIS FACTOR INHIBITOR TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Druce, Katie L.
    De Cock, Diederik
    Watson, Kath
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2017, 56 : 68 - 68
  • [44] Systematic Review of Tumor Necrosis Factor Inhibitor Discontinuation Studies in Rheumatoid Arthritis
    Navarro-Millan, Iris
    Sattui, Sebastian E.
    Curtis, Jeffrey R.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (11) : 1850 - 1861
  • [45] Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
    Perpetuo, Ines P.
    Caetano-Lopes, Joana
    Rodrigues, Ana Maria
    Campanilho-Marques, Raquel
    Ponte, Cristina
    Canhao, Helena
    Ainola, Mari
    Fonseca, Joao E.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [46] Dosing patterns and costs of tumor necrosis factor inhibitor use for rheumatoid arthritis
    Harrison, David J.
    Huang, Xingyue
    Globe, Denise
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : 1281 - 1287
  • [47] CAN ULTRASONOGRAPHIC FINDINGS PREDICT RESPONSE TO TUMOR NECROSIS FACTOR-A INHIBITOR TREATMENT IN RHEUMATOID ARTHRITIS?
    Inanc, N.
    Ozen, G.
    Direskeneli, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 544 - 545
  • [48] TREATMENT EFFECTIVENESS FOR RHEUMATOID ARTHRITIS AFTER SWITCHING FROM A TUMOR NECROSIS FACTOR INHIBITOR TO ANOTHER AGENT
    Bonafede, M.
    Curtis, J. R.
    McMorrow, D.
    Mahajan, P.
    Chen, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1026 - 1026
  • [49] SUCCESS RATES IN SWITCHING TO AN ALTERNATIVE TUMOUR NECROSIS FACTOR INHIBITOR FOLLOWING TREATMENT FAILURE IN RHEUMATOID ARTHRITIS
    Hughes, Mark
    Wijeyekoon, Jananath
    [J]. RHEUMATOLOGY, 2017, 56 : 204 - 204
  • [50] Tumor necrosis factor-α inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis
    Bosello, S
    De Santis, M
    Tolusso, B
    Zoli, A
    Ferraccioli, G
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (12) : 918 - 920
12345